Search research articles
Contact Us
Filters
Showing results (21-30 of 68) with videos related to
Page
of 7
Sort By:
Journal of the American Society of Nephrology : JASN
|
November 9, 2017
Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function
Bing Guo, Qing Lyu, Orazio J Slivano, et al.
Cancer Research
|
June 7, 2018
<i>Kras</i> and <i>Tp53</i> Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma
Margaret A Hill, William B Alexander, Bing Guo, et al.
Cancer Research
|
July 13, 2012
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression
Aram F Hezel, Vikram Deshpande, Stephanie M Zimmerman, et al.
Clinical Colorectal Cancer
|
May 16, 2020
Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience
Franklin Li, Gradon Nielsen, Andrea Baran, et al.
Genes & Development
|
November 23, 2006
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy, Kuang-Hung Cheng, Justin H Berger, et al.
Cancer Research
|
January 24, 2012
Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma
Michael R O'Dell, Jing Li Huang, Christa L Whitney-Miller, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Advances in Radiation Oncology
|
August 12, 2017
Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
Mostafa Mohamed, Alan W Katz, Mohamedtaki A Tejani, et al.
Human Pathology
|
February 2, 2024
SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study
Irene Y Chen, Mark G Ettel, Phoenix D Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer
Brian M Wolpin, Aram F Hezel, Thomas Abrams, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 68) with videos related to
Sort By:
Page
of 7
Journal of the American Society of Nephrology : JASN
|
November 9, 2017
Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function
Bing Guo, Qing Lyu, Orazio J Slivano, et al.
Cancer Research
|
June 7, 2018
<i>Kras</i> and <i>Tp53</i> Mutations Cause Cholangiocyte- and Hepatocyte-Derived Cholangiocarcinoma
Margaret A Hill, William B Alexander, Bing Guo, et al.
Cancer Research
|
July 13, 2012
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression
Aram F Hezel, Vikram Deshpande, Stephanie M Zimmerman, et al.
Clinical Colorectal Cancer
|
May 16, 2020
Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience
Franklin Li, Gradon Nielsen, Andrea Baran, et al.
Genes & Development
|
November 23, 2006
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy, Kuang-Hung Cheng, Justin H Berger, et al.
Cancer Research
|
January 24, 2012
Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma
Michael R O'Dell, Jing Li Huang, Christa L Whitney-Miller, et al.
Cancer
|
April 2, 2015
Phase 2 study of MK-2206, an allosteric inhibitor of AKT, as second-line therapy for advanced gastric and gastroesophageal junction cancer: A SWOG cooperative group trial (S1005)
Ramesh K Ramanathan, Shannon L McDonough, Hagen F Kennecke, et al.
Advances in Radiation Oncology
|
August 12, 2017
Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma
Mostafa Mohamed, Alan W Katz, Mohamedtaki A Tejani, et al.
Human Pathology
|
February 2, 2024
SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study
Irene Y Chen, Mark G Ettel, Phoenix D Bell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2008
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer
Brian M Wolpin, Aram F Hezel, Thomas Abrams, et al.
Page
of 7